J9275 Injection cosibelimab-ipdl, 2 milligrams
J-Codes
Also known as: cosibelimab, Libtayo
Injection of cosibelimab-ipdl, 2 milligram. A PD-L1 monoclonal antibody checkpoint inhibitor for cutaneous squamous cell carcinoma.
Clinical Context
Used for advanced cutaneous squamous cell carcinoma in immunocompromised patients. Provides response rates in those ineligible for chemotherapy or surgery.
RVU Breakdown
| Work RVU | 0.00 |
| Practice Expense RVU | 0.00 |
| Malpractice RVU | 0.00 |
| Total RVU | 0.00 |
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.